Virulence and Resistance Mechanisms in Multidrug-Resistant Acinetobacter baumannii
Pathogens · 28.07.2026 · 15 (8) · 798
DOI: 10.3390/pathogens15080798 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 28.07.2026. Verfasst von Priya Rajendran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology, ICMR-National Institute for Research in Tuberculosis, Chennai 600031, India. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Bacterial, Acinetobacter baumannii, Acinetobacter Infections. Die Arbeit nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acinetobacter baumannii, a Gram-negative opportunistic bacterium in the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, A. baumannii, Pseudomonas aeruginosa and Enterobacter spp.), has emerged as a leading cause of nosocomial infections worldwide. It is known to possess diverse virulence traits and antimicrobial resistance, making it a critical priority pathogen on the World Health Organization’s 2024 Bacterial Priority Pathogens List. Carbapenem-resistant A. baumannii (CRAB) is currently endemic across several continents, with global carbapenem resistance exceeding 70% in healthcare settings and multidrug-resistant infections being associated with alarming mortality rates. This review comprehensively discusses the molecular underpinnings of A. baumannii pathogenesis and virulence, detailing the array of factors coordinated by complex regulatory networks. The convergence of this pathogen’s virulence and antimicrobial resistance traits, resulting in multidrug resistance, leaves clinicians with only a handful of therapeutic options. The review also discusses upcoming therapeutic strategies, including phage therapy, antimicrobial peptides, monoclonal antibodies, photodynamic therapy, and vaccine candidates in the pipeline. While emerging therapeutics show promise, several challenges remain, and integrated approaches are warranted to efficiently combat A. baumannii’s virulence and resistance armamentarium.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bacteriology, ICMR-National Institute for Research in Tuberculosis, Chennai 600031, India.
- Department of Microbiology, School of Life Sciences, Central University of Rajasthan, Ajmer 305817, India.
- Department of Microbiology, The American College, Madurai 625002, India.
- Department of Microbiology, Sree Balaji Medical College and Hospital, Chennai 600044, India.
- Anderson Diagnostics & Labs, Chennai 600006, India.
- Preclinical Department, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh 30450, Malaysia.
ORCID-Profile: Priya Rajendran, Renuka James, Bindu Dhanapal, Ramachandran Vignesh
Zitieren
APA
Rajendran, P., Marimuthu Ragavan, R., James, R., Dhanapal, B., Venkatachalam, M., Reghupathy, J., & Vignesh, R. (2026). Virulence and Resistance Mechanisms in Multidrug-Resistant Acinetobacter baumannii. Pathogens, 15(8), 798. https://doi.org/10.3390/pathogens15080798
Vancouver
Rajendran P, Marimuthu Ragavan R, James R, Dhanapal B, Venkatachalam M, Reghupathy J, et al. Virulence and Resistance Mechanisms in Multidrug-Resistant Acinetobacter baumannii. Pathogens. 2026;15(8):798. doi:10.3390/pathogens15080798
BibTeX
@article{Rajendran2026,
author = {Rajendran, Priya and Marimuthu Ragavan, Rameshkumar and James, Renuka and Dhanapal, Bindu and Venkatachalam, Mullai and Reghupathy, Jeevarahini and Vignesh, Ramachandran},
title = {Virulence and Resistance Mechanisms in Multidrug-Resistant Acinetobacter baumannii},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {8},
pages = {798},
doi = {10.3390/pathogens15080798}
}
EUVIMED